Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 773 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Results in Greater EFS and pCR... November 6, 2023 FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer June 27, 2025 Being Diagnosed With a Childhood Cancer As an Adult Led Me... May 18, 2023 Synchronized Swimmer Learns She Has Breast Cancer After Teammate Kicks Her... March 4, 2020 Load more HOT NEWS Study Finds the Cost of Treating Metastatic Breast Cancer Could More... Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not... Popular Fitness Instructor Encourages Others to Maintain Routine Check Ups After...
